Avadel Pharmaceuticals Gross Margin 2012-2025 | AVDL

Current and historical gross margin for Avadel Pharmaceuticals (AVDL) over the last 10 years. The current gross profit margin for Avadel Pharmaceuticals as of September 30, 2025 is %.
Avadel Pharmaceuticals Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-09-30 $0.25B $0.24B 95.56%
2025-06-30 $0.22B $0.20B 90.05%
2025-03-31 $0.20B $0.18B 90.26%
2024-12-31 $0.17B $0.16B 91.72%
2024-09-30 $0.14B $0.13B 92.75%
2024-06-30 $0.10B $0.09B 95.79%
2024-03-31 $0.05B $0.05B 98.15%
2020-06-30 $0.05B $0.04B 78.72%
2020-03-31 $0.06B $0.04B 80.00%
2019-12-31 $0.06B $0.05B 79.66%
2019-09-30 $0.07B $0.06B 79.71%
2019-06-30 $0.08B $0.06B 81.33%
2019-03-31 $0.09B $0.07B 84.88%
2018-12-31 $0.10B $0.09B 84.47%
2018-09-30 $0.12B $0.10B 86.32%
2018-06-30 $0.14B $0.12B 87.59%
2018-03-31 $0.15B $0.14B 88.31%
2017-12-31 $0.17B $0.16B 90.80%
2017-09-30 $0.18B $0.17B 91.76%
2017-06-30 $0.17B $0.16B 91.95%
2017-03-31 $0.17B $0.15B 91.62%
2016-12-31 $0.15B $0.14B 90.67%
2016-09-30 $0.15B $0.14B 90.67%
2016-06-30 $0.17B $0.15B 92.12%
2016-03-31 $0.18B $0.16B 93.14%
2015-12-31 $0.17B $0.16B 93.02%
2015-09-30 $0.13B $0.13B 94.70%
2015-06-30 $0.09B $0.09B 92.39%
2015-03-31 $0.05B $0.05B 88.24%
2014-12-31 $0.03B $0.02B 85.19%
2014-09-30 $0.03B $0.03B 93.33%
2014-06-30 $0.03B $0.03B 93.10%
2014-03-31 $0.03B $0.03B 92.59%
2013-12-31 $0.02B $0.02B 95.65%
2013-09-30 $0.02B $0.02B 75.00%
2013-06-30 $0.02B $0.02B 78.26%
2013-03-31 $0.02B $0.02B 82.61%
2012-12-31 $0.03B $0.02B 84.00%
2012-09-30 $0.03B $0.02B 81.48%
2012-06-30 $0.03B $0.03B 84.38%
2012-03-31 $0.03B $0.03B 81.82%
2011-12-31 $0.03B $0.03B 78.79%
2011-09-30 $0.04B $0.03B 83.78%
2011-06-30 $0.04B $0.03B 82.86%
2011-03-31 $0.04B $0.03B 83.33%
2010-12-31 $0.04B $0.03B 83.78%
2010-09-30 $0.04B $0.03B 74.29%
2010-06-30 $0.04B $0.03B 70.27%
2010-03-31 $0.04B $0.03B 71.79%
2009-12-31 $0.04B $0.03B 74.42%
2009-09-30 $0.04B $0.03B 78.05%
2009-06-30 $0.04B $0.03B 80.00%
2009-03-31 $0.04B $0.03B 79.49%
2008-12-31 $0.04B $0.03B 76.32%
2008-09-30 $0.04B $0.03B 70.00%
2008-06-30 $0.04B $0.03B 65.00%
2008-03-31 $0.04B $0.02B 60.53%
2007-12-31 $0.04B $0.02B 54.05%
2007-09-30 $0.03B $0.02B 61.76%
2007-06-30 $0.03B $0.02B 66.67%
2007-03-31 $0.03B $0.02B 71.43%
2006-12-31 $0.02B $0.02B 78.26%
2006-09-30 $0.02B $0.02B 80.95%
2006-06-30 $0.02B $0.02B 78.95%
2006-03-31 $0.02B $0.02B 80.00%
2005-12-31 $0.02B $0.02B 91.30%
2005-09-30 $0.04B $0.03B 91.67%
2005-06-30 $0.05B $0.04B 93.48%
2005-03-31 $0.05B $0.05B 93.88%
2004-12-31 $0.06B $0.05B 94.55%
2004-09-30 $0.05B $0.04B 93.62%
2004-06-30 $0.04B $0.04B 92.31%
2004-03-31 $0.04B $0.03B 91.43%
2003-12-31 $0.03B $0.02B 80.00%
2003-09-30 $0.02B $0.01B 73.68%
2003-06-30 $0.02B $0.02B 80.00%
2003-03-31 $0.02B $0.02B 84.21%
2002-12-31 $0.02B $0.02B 95.00%
2002-09-30 $0.02B $0.02B 100.00%
2002-06-30 $0.02B $0.02B 100.00%
2002-03-31 $0.02B $0.02B 100.00%
2001-12-31 $0.01B $0.01B 100.00%
2001-09-30 $0.01B $0.01B 100.00%
2001-06-30 $0.01B $0.01B 100.00%
2001-03-31 $0.01B $0.01B 100.00%
2000-12-31 $0.01B $0.01B 100.00%
2000-09-30 $0.02B $0.02B 100.00%
2000-06-30 $0.01B $0.01B 100.00%
2000-03-31 $0.01B $0.01B 100.00%
1999-12-31 $0.01B $0.01B 100.00%
1999-06-30 $0.01B $0.01B 100.00%
1999-03-31 $0.01B $0.01B 100.00%
1998-12-31 $0.01B $0.01B 100.00%
1998-09-30 $0.01B $0.01B 100.00%
1998-06-30 $0.01B $0.01B 100.00%
1998-03-31 $0.01B $0.01B 100.00%
1997-12-31 $0.01B $0.01B 100.00%
1997-09-30 $0.01B $0.01B 100.00%
1997-06-30 $0.01B $0.01B 100.00%
1997-03-31 $0.01B $0.01B 100.00%
1996-12-31 $0.01B $0.01B 100.00%
1996-09-30 $0.01B $0.01B 100.00%
1996-06-30 $0.00B $0.00B 100.00%
1996-03-31 $0.00B $0.00B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.098B $0.169B
Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.303B 32.40
Zoetis (ZTS) United States $54.932B 19.66
Takeda Pharmaceutical (TAK) Japan $51.421B 10.49
Daiichi Sankyo, - (DSNKY) Japan $39.630B 19.74
BeOne Medicines - (ONC) Switzerland $37.087B 196.62
Sandoz Group AG (SDZNY) Switzerland $33.939B 0.00
United Therapeutics (UTHR) United States $20.018B 17.62
Merck (MKKGY) Germany $19.496B 12.02
Shionogi (SGIOY) Japan $15.261B 14.02
Neurocrine Biosciences (NBIX) United States $13.200B 31.67
Summit Therapeutics (SMMT) United States $13.140B 0.00
IPSEN (IPSEY) France $13.109B 0.00
Ionis Pharmaceuticals (IONS) United States $12.363B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.394B 0.00
Orion OYJ (ORINY) Finland $10.204B 29.15
Eisai (ESAIY) $8.236B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.576B 20.00
Stevanato Group S.p.A (STVN) Italy $5.981B 33.47
Crinetics Pharmaceuticals (CRNX) United States $5.313B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.613B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.216B 20.01
Indivior (INDV) United States $4.068B 16.60
Corcept Therapeutics (CORT) United States $3.653B 39.47
NewAmsterdam Pharma (NAMS) Netherlands $3.589B 0.00
Hypermarcas (HYPMY) Brazil $3.047B 20.91
Centessa Pharmaceuticals (CNTA) United Kingdom $2.984B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.790B 8.90
Ocular Therapeutix (OCUL) United States $2.401B 0.00
Dyne Therapeutics (DYN) United States $2.386B 0.00
Soleno Therapeutics (SLNO) United States $2.282B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.958B 23.20
Harrow (HROW) United States $1.774B 108.86
Guardian Pharmacy Services (GRDN) United States $1.712B 32.96
Ardelyx (ARDX) United States $1.640B 0.00
Oruka Therapeutics (ORKA) United States $1.617B 0.00
Enliven Therapeutics (ELVN) United States $1.585B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.570B 0.00
Collegium Pharmaceutical (COLL) United States $1.441B 7.14
BioCryst Pharmaceuticals (BCRX) United States $1.404B 83.25
Evotec AG (EVO) Germany $1.282B 0.00
Relay Therapeutics (RLAY) United States $1.274B 0.00
Xeris Biopharma Holdings (XERS) United States $1.248B 0.00
Savara (SVRA) United States $1.184B 0.00
ARS Pharmaceuticals (SPRY) United States $1.051B 0.00
Theravance Biopharma (TBPH) United States $1.014B 42.57
Cronos Group (CRON) Canada $0.967B 0.00
Xencor (XNCR) United States $0.913B 0.00
Nektar Therapeutics (NKTR) United States $0.766B 0.00
KalVista Pharmaceuticals (KALV) United States $0.738B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.732B 17.31
Esperion Therapeutics (ESPR) United States $0.727B 0.00
ProKidney (PROK) United States $0.689B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.680B 6.07
Bioventus (BVS) United States $0.656B 13.44
Lexeo Therapeutics (LXEO) United States $0.539B 0.00
Elite Pharmaceuticals (ELTP) United States $0.506B 0.00
Lyell Immunopharma (LYEL) United States $0.505B 0.00
Zevra Therapeutics (ZVRA) United States $0.503B 0.00
Organogenesis (ORGO) United States $0.481B 0.00
Siga Technologies (SIGA) United States $0.471B 6.45
Altimmune (ALT) United States $0.442B 0.00
4D Molecular Therapeutics (FDMT) United States $0.431B 0.00
Nature's Sunshine Products (NATR) United States $0.421B 25.07
Aquestive Therapeutics (AQST) United States $0.404B 0.00
USANA Health Sciences (USNA) United States $0.401B 11.19
Akebia Therapeutics (AKBA) United States $0.361B 0.00
Achieve Life Sciences (ACHV) Canada $0.310B 0.00
Profound Medical (PROF) Canada $0.298B 0.00
Aclaris Therapeutics (ACRS) United States $0.284B 0.00
Avalo Therapeutics (AVTX) United States $0.279B 0.00
Aldeyra Therapeutics (ALDX) United States $0.279B 0.00
Relmada Therapeutics (RLMD) United States $0.274B 0.00
OmniAb (OABI) United States $0.274B 0.00
Heron Therapeutics (HRTX) United States $0.273B 0.00
Fractyl Health (GUTS) United States $0.262B 0.00
Larimar Therapeutics (LRMR) United States $0.259B 0.00
Protara Therapeutics (TARA) United States $0.259B 0.00
Silence Therapeutics (SLN) United Kingdom $0.238B 0.00
Enlivex Therapeutics (ENLV) Israel $0.223B 0.00
Journey Medical (DERM) United States $0.217B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.209B 0.00
Galectin Therapeutics (GALT) United States $0.196B 0.00
Minerva Neurosciences (NERV) United States $0.193B 0.00
Century Therapeutics (IPSC) United States $0.190B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
MediWound (MDWD) Israel $0.180B 0.00
Surrozen (SRZN) United States $0.171B 0.00
AleAnna (ANNA) United States $0.171B 0.00
VAXART, INC (VXRT) United States $0.169B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.161B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.146B 0.00
Unicycive Therapeutics (UNCY) United States $0.133B 0.00
Context Therapeutics (CNTX) United States $0.132B 0.00
Incannex Healthcare (IXHL) Australia $0.131B 0.00
Inhibikase Therapeutics (IKT) United States $0.126B 0.00
Avita Medical (RCEL) United States $0.119B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.116B 0.00
Karyopharm Therapeutics (KPTI) United States $0.116B 0.00
Prelude Therapeutics (PRLD) United States $0.114B 0.00
Pyxis Oncology (PYXS) United States $0.110B 0.00
Cardiol Therapeutics (CRDL) Canada $0.105B 0.00
Champions Oncology (CSBR) United States $0.100B 42.41
Cassava Sciences (SAVA) United States $0.099B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
Korro Bio (KRRO) United States $0.083B 0.00
Assertio Holdings (ASRT) United States $0.074B 0.00
Gain Therapeutics (GANX) United States $0.070B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.070B 58.13
PolyPid (PYPD) Israel $0.069B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
NRx Pharmaceuticals (NRXP) United States $0.067B 0.00
Arch Biopartners (ACHFF) Canada $0.066B 0.00
Rafael Holdings (RFL) United States $0.064B 0.00
Acrivon Therapeutics (ACRV) United States $0.062B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Lipocine (LPCN) United States $0.062B 0.00
PMV Pharmaceuticals (PMVP) United States $0.060B 0.00
ElectroCore (ECOR) United States $0.057B 0.00
Nutriband (NTRB) United States $0.053B 0.00
Lite Strategy (LITS) United States $0.053B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
Talphera (TLPH) United States $0.047B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
Plus Therapeutics (PSTV) United States $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Kyntra Bio Inc (KYNB) United States $0.037B 0.00
Wellgistics Health (WGRX) United States $0.036B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.030B 0.00
Jupiter Neurosciences (JUNS) United States $0.030B 0.00
Natural Alternatives (NAII) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.026B 0.00
Klotho Neurosciences (KLTO) United States $0.024B 0.00
Scienture Holdings (SCNX) United States $0.022B 0.00
Liminatus Pharma (LIMN) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.020B 0.00
Inotiv (NOTV) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.016B 0.02
Vyome Holdings (HIND) United States $0.016B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Tempest Therapeutics (TPST) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Ainos (AIMD) United States $0.009B 0.00
BioVie (BIVI) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Decoy Therapeutics Inc (DCOY) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Lyra Therapeutics (LYRA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.003B 0.00
CDT Equity (CDT) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00